In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor Agents.
Mediha AssadRizwan Nasir ParachaAbu Bakar SiddiqueMuhammad Ashraf ShaheenNadeem AhmadMuhammad MustaqeemFariha KanwalMuhammad Zia Ul MustafaMuhammad Fayyaz Ur RehmanSumaya FatimaChangrui LuPublished in: Molecules (Basel, Switzerland) (2023)
The present study reports the one-step synthesis of several 3-formyl-4-hydroxycouramin-derived enamines ( 4a - 4i ) in good yields (65-94%). The characterization of the synthesized compounds was carried out via advanced analytical and spectroscopic techniques, such as melting point, electron impact mass spectrometry (EI-MS), 1 H-NMR, 13 C-NMR, elemental analysis, FTIR, and UV-Visible spectroscopy. The reaction conditions were optimized, and the maximum yield was obtained at 3-4 h of reflux of the reactants, using 2-butanol as a solvent. The potato disc tumor assay was used to assess Agrobacterium tumefaciens -induced tumors to evaluate the anti-tumor activities of compounds ( 4a - 4i ), using Vinblastine as a standard drug. The compound 4g showed the lowest IC 50 value (1.12 ± 0.2), which is even better than standard Vinblastine (IC 50 7.5 ± 0.6). For further insight into their drug actions, an in silico docking of the compounds was also carried out against the CDK-8 protein. The binding energy values of compounds were found to agree with the experimental results. The compounds 4g and 4h showed the best affinities toward protein, with a binding energy value of -6.8 kcal/mol.
Keyphrases
- high resolution
- mass spectrometry
- molecular docking
- protein protein
- magnetic resonance
- binding protein
- liquid chromatography
- solid state
- adverse drug
- multiple sclerosis
- ms ms
- cell cycle
- emergency department
- molecular dynamics simulations
- amino acid
- small molecule
- dna binding
- climate change
- transcription factor
- aqueous solution